Literature DB >> 24214179

Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis.

David E Victorson1, Seung Choi, Marc A Judson, David Cella.   

Abstract

PURPOSE: Sarcoidosis is a multisystem disease that can negatively impact health-related quality of life (HRQL) across generic (e.g., physical, social and emotional wellbeing) and disease-specific (e.g., pulmonary, ocular, dermatologic) domains. Measurement of HRQL in sarcoidosis has largely relied on generic patient-reported outcome tools, with little disease-specific measures available. The purpose of this paper is to present the development and testing of disease-specific item banks and short forms of lung, skin and eye problems, which are a part of a new patient-reported outcome (PRO) instrument called the sarcoidosis assessment tool.
METHODS: After prioritizing and selecting the most important disease-specific domains, we wrote new items to reflect disease-specific problems by drawing from patient focus group and clinician expert survey data that were used to create our conceptual model of HRQL in sarcoidosis. Item pools underwent cognitive interviews by sarcoidosis patients (n = 13), and minor modifications were made. These items were administered in a multi-site study (n = 300) to obtain item calibrations and create calibrated short forms using item response theory (IRT) approaches.
RESULTS: From the available item pools, we created four new item banks and short forms: (1) skin problems, (2) skin stigma, (3) lung problems, and (4) eye Problems. We also created and tested supplemental forms of the most common constitutional symptoms and negative effects of corticosteroids.
CONCLUSIONS: Several new sarcoidosis-specific PROs were developed and tested using IRT approaches. These new measures can advance more precise and targeted HRQL assessment in sarcoidosis clinical trials and clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 24214179     DOI: 10.1007/s11136-013-0567-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  36 in total

1.  An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment.

Authors:  M A Judson
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

2.  Item response theory and health outcomes measurement in the 21st century.

Authors:  R D Hays; L S Morales; S P Reise
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

Review 3.  Quality of life in sarcoidosis: assessment and management.

Authors:  Jolanda De Vries; Elyse E Lower; Marjolein Drent
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

4.  Developing a contemporary patient-reported outcomes measure for spinal cord injury.

Authors:  David S Tulsky; Pamela A Kisala; David Victorson; Denise Tate; Allen W Heinemann; Dagmar Amtmann; David Cella
Journal:  Arch Phys Med Rehabil       Date:  2011-10       Impact factor: 3.966

5.  Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease.

Authors:  Leorey N Saligan; Grace Levy-Clarke; Tongtong Wu; Lisa J Faia; Keith Wroblewski; Steven Yeh; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

6.  PROMIS: a new tool for the clinician scientist.

Authors:  Douglas M Lawson
Journal:  J Can Chiropr Assoc       Date:  2011-03

7.  Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments.

Authors:  Daniel J Buysse; Lan Yu; Douglas E Moul; Anne Germain; Angela Stover; Nathan E Dodds; Kelly L Johnston; Melissa A Shablesky-Cade; Paul A Pilkonis
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

Review 8.  Epidemiology of sarcoidosis: recent advances and future prospects.

Authors:  Benjamin A Rybicki; Michael C Iannuzzi
Journal:  Semin Respir Crit Care Med       Date:  2007-02       Impact factor: 3.119

9.  The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status.

Authors:  Amit Suresh Patel; Richard J Siegert; Daniel Creamer; Genevieve Larkin; Toby M Maher; Elisabetta A Renzoni; Athol U Wells; Irene J Higginson; Surinder S Birring
Journal:  Thorax       Date:  2012-10-12       Impact factor: 9.139

10.  Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis.

Authors:  Willemien P E de Kleijn; Marjolein Drent; Jolanda De Vries
Journal:  Br J Health Psychol       Date:  2012-09-18
View more
  5 in total

1.  Refining and supplementing candidate measures of psychological well-being for the NIH PROMIS®: qualitative results from a mixed cancer sample.

Authors:  John M Salsman; Crystal L Park; Elizabeth A Hahn; Mallory A Snyder; Login S George; Michael F Steger; Thomas Merluzzi; David Cella
Journal:  Qual Life Res       Date:  2018-06-20       Impact factor: 4.147

Review 2.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

3.  The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.

Authors:  Marc A Judson; Haroon Chaudhry; Amanda Louis; Kevin Lee; Recai Yucel
Journal:  Respir Med       Date:  2015-02-07       Impact factor: 3.415

4.  Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.

Authors:  Brooke M Currie; Evan W Davies; Amélie Beaudet; Larissa Stassek; Leah Kleinman; Robert P Baughman
Journal:  BMC Pulm Med       Date:  2021-11-12       Impact factor: 3.317

5.  Depression, stigma and social isolation: the psychosocial trifecta of primary chronic cutaneous lupus erythematosus, a cross-sectional and path analysis.

Authors:  Cristina Drenkard; Kristina A Theis; Timothy T Daugherty; Charles G Helmick; Charmayne Dunlop-Thomas; Gaobin Bao; Laura Aspey; Tené T Lewis; S Sam Lim
Journal:  Lupus Sci Med       Date:  2022-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.